Attached files
| file | filename |
|---|---|
| 10-K/A - FORM 10-K/A AMENDED ANNUAL REPORT - PROTO SCRIPT PHARMACEUTICAL CORP | f10ka053116_10kz.htm |
| EX-31.1 - EXHIBIT 31.1 SECTION 302 CERTIFICATION - PROTO SCRIPT PHARMACEUTICAL CORP | f10ka053116_ex31z1.htm |
EXHIBIT 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
I, Michelle Rico, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1)
the Annual Report on Form 10-K/A of Yanex Group, Inc. for the year ended May 31, 2016 (the "Report") fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)
the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Yanex Group, Inc.
Dated: November 4, 2016 |
|
|
|
|
|
|
|
|
|
| /s/ Michelle Rico |
|
| Michelle Rico |
|
| President, Chief Executive Officer, Chief Financial Officer, Treasurer and Director |
|
| (Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer) |
|
|
|